Extended Donors in Liver Transplantation

Clinics in Liver Disease

Volumn 15, Issue 4, 2011, Pages 879-900

  Harring, Theresa R ^a   O'Mahony, Christine A ^a   Goss, John A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Advanced age; Deceased after cardiac death; Extended criteria donor; Liver transplant; Marginal donor; Steatosis

Indexed keywords

ANTIBIOTIC AGENT;

ADVANCED DONOR AGE; AGE; BLOOD GROUP ABO INCOMPATIBILITY; COLD ISCHEMIA TIME; DECEASED AFTER CARDIAC DEATH; DONOR; GRAFT SURVIVAL; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; LIVER TRANSPLANTATION; LIVING DONOR; NONHUMAN; REVIEW; SPLIT LIVER TRANSPLANTATION; STEATOSIS; SURGICAL TECHNIQUE; SURVIVAL RATE; TIME;

DELTARETROVIRUS INFECTIONS; FATTY LIVER; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; INCIDENCE; LIVER TRANSPLANTATION; LIVING DONORS; MALE; PATIENT SELECTION; PREVALENCE; TISSUE DONORS; WAITING LISTS;

EID: 80054889171     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2011.08.006     Document Type: Review

References (126)

1. The United Network for Organ Sharing/Organ Procurement and Transplantation Network. Available at: Accessed March 21, 2011. http://optn.transplant.hrsa.gov.
2. Berg C.L., Steffick D.E., Edwards E.B., et al. Liver and Intestine Transplantation in the United States 1998-2007. Am J Transplant 2009, 9(2):907-931.
3. Foley D.P., Fernandez L.A., Leverson G., et al. Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg 2005, 242(5):724-731.
4. Nguyen J.H., Bonatti H., Dickson R.C., et al. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant 2009, 23:168-173.
5. Detry O., Seydel B., Delbouille M.H., et al. Liver transplant donation after cardiac death: experience at the University of Liege. Transplant Proc 2009, 41:582-584.
6. de Vera M.E., Lopez-Solis R., Dvorchik I., et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009, 9:773-781.
7. Chan E.Y., Olson L.C., Kisthard J.A., et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl 2008, 14:604-610.
8. Mateo R., Cho Y., Singh G., et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006, 6:791-796.
9. Merion R.M., Pelletier S.J., Goodrich N., et al. Donation after cardiac death as a strategy to increase deceased donor liver availability. Ann Surg 2006, 244(4):555-562.
10. Doshi M.D., Hunsicker L.G. Short- and long-term outcomes with the use of kidneys and livers donated after cardiac death. Am J Transplant 2007, 7:122-129.
11. Maheshwari A., Maley W., Li Z., et al. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transpl 2007, 13:1645-1653.
12. Yagci G., Fernandez L.A., Knechtle S.J., et al. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Transplant Proc 2008, 40:219-223.
13. Singhal A., Sezginsoy B., Ghuloom A.E., et al. Orthotopic liver transplant using allografts from geriatric population in the United States: is there any age limit?. Exp Clin Transplant 2010, 8(3):196-201.
14. Rauchfuss F., Voigt R., Dittmar Y., et al. Liver transplantation utilizing old donor organs: a German Single-Center Experience. Transplant Proc 2010, 42:175-177.
15. Zapletal C.H., Faust D., Wullstein C., et al. Does the liver ever age? Results of liver transplantation with donors above 80 years of age. Transplant Proc 2005, 37:1182-1185.
16. Cascales-Campos P.A., Romero P.R., Gonzalez R., et al. Improving the waiting list by using 75-year-old donors for recipients with hepatocellular carcinoma. Transplant Proc 2010, 42:627-630.
17. Emre S., Schwartz M.E., Altaca G., et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation 1996, 62(1):62-65.
18. Grazi G.L., Cescon M., Ravaioli M., et al. A revised consideration on the use of very aged donors for liver transplantation. Am J Transplant 2001, 1:61-68.
19. Grande L., Rull A., Rimola A., et al. Outcome of patients undergoing orthotopic liver transplantation with elderly donors (over 60 years). Transplant Proc 1997, 29:3289-3290.
20. Nardo B., Masetti M., Urbani L., et al. Liver transplantation from donors aged 80 years and over: pushing the limit. Am J Transplant 2004, 4:1139-1147.
21. Cescon M., Grazi G.L., Ercolani G., et al. Long-term survival of recipients of liver grafts from donors older than 80 years: is it achievable?. Liver Transpl 2003, 9(11):1174-1180.
22. Petridis I., Gruttadauria S., Nadalin S., et al. Liver transplantation using donors older than 80 years: a single-center experience. Transplant Proc 2008, 40:1976-1978.
23. Washburn W.K., Johnson L.B., Lewis W.D., et al. Graft function and outcome of older (> or = 60 years) donor livers. Transplantation 1996, 61(7):1062-1066.
24. Busquets J., Xiol X., Figueras J., et al. The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation 2001, 71(12):1765-1771.
25. Marino I.R., Doyle H.R., Doria C., et al. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc 1995, 27(1):1184-1185.
26. Hoofnagle J.H., Lombardero M., Zetterman R.K., et al. Donor age and outcome of liver transplantation. Hepatology 1996, 24(1):89-96.
27. Romero C.J., Gonzalez E.M., Ruiz F.C., et al. Use of octogenarian livers safely expands the donor pool. Transplantation 1999, 68(4):572-575.
28. Ravaioli M., Grazi G.L., Cescon M., et al. Liver transplantations with donors aged 60 years and above: the low liver damage strategy. Transpl Int 2009, 22:423-433.
29. Ikegami T., Nishizaki T., Yanaga K., et al. The impact of donor age on living donor liver transplantation. Transplantation 2000, 70(12):1703-1707.
30. Tallon-Aguilar L., Molina-Garcia D., Barrera-Pulido, et al. Influence of donor age on survival in liver transplantation due to hepatitis C virus. Transplant Proc 2008, 40:2968-2970.
31. Perez-Daga J.A., Ramirez-Plaza C., Suarez M.A., et al. Impact of donor age on the results of liver transplantation in hepatitis C virus-positive recipients. Transplant Proc 2008, 40:2959-2961.
32. Condron S.L., Heneghan M.A., Patel K., et al. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation 2005, 80(1):145-148.
33. Totsuka E., Fung J.J., Lee M.C., et al. Influence of cold ischemia time and graft transport distance on postoperative outcome in human liver transplantation. Surg Today 2002, 32:792-799.
34. Furukawa H., Todo S., Imventarza O., et al. Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution. Transplantation 1991, 51(5):1000-1004.
35. Dipchand A.I., Pollock BarZiv S.M., Manlhiot C., et al. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2010, 10:389-397.
36. Everitt M.D., Donaldson A.E., Casper T.C., et al. Effect of ABO-incompatible listing on infant heart transplant waitlist outcomes: analysis of the United Network for Organ Sharing (UNOS) database. J Heart Lung Transplant 2009, 28:1254-1260.
37. Almond C.S., Gauvreau K., Thiagarajan R.R., et al. Impact of ABO-incompatible listing on wait-list outcomes among infants listed for heart transplantation in the United States: a propensity analysis. Circulation 2010, 121:1926-1933.
38. Saczkowski R., Dacey C., Bernier P.L. Does ABO-incompatible and ABO-compatible neonatal heart transplant have equivalent survival?. Interact Cardiovasc Thorac Surg 2010, 10:1026-1033.
39. Urschel S., Campbell P.M., Meyer S.R., et al. Absence of donor-specific anti-HLA antibodies after ABO-incompatible heart transplantation in infancy: altered immunity or age?. Am J Transplant 2010, 10:149-156.
40. Gambino A., Torregrossa G., Cozzi E., et al. ABO-incompatible heart transplantation: crossing the immunological barrier. J Cardiovasc Med 2008, 9:854-857.
41. Patel N.D., Weiss E.S., Scheel J., et al. ABO-incompatible heart transplantation in infants: analysis of the united network for organ sharing database. J Heart Lung Transplant 2008, 27:1085-1089.
42. Stewart Z.A., Locke J.E., Montgomery R.A., et al. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis. Liver Transpl 2009, 15:883-893.
43. Tanabe M., Kawachi S., Obara H., et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest 2010, 40(10):943-949.
44. Preiss D., Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci 2008, 115:141-150.
45. Farrell G.C., Larter C.Z. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006, 43:S99-S112.
46. Rey J.W., Wirges U., Dienes H.P., et al. Hepatic steatosis in organ donors: disparity between surgery and histology?. Transplant Proc 2009, 41:2557-2560.
47. Angele M.K., Rentsch M., Hartl W.H., et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg 2008, 195:214-220.
48. Avolio A.W., Frongillo F., Nicolotti N., et al. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27. Transplant Proc 2009, 41:208-212.
49. Aberg F., Pukkala E., Hockerstedt K., et al. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008, 14:1428-1436.
50. Haagsma E.B., Hagens V.E., Schaapveld M., et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001, 34:84-91.
51. Saigal S., Norris S., Srinivasan P., et al. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states. Liver Transpl 2001, 7(1):11-15.
52. Benten D., Sterneck M., Panse J., et al. Low recurrence of preexisting extrahepatic malignancies after liver transplantation. Liver Transpl 2008, 14:789-798.
53. Ortiz J.A., Manzarbeitia C., Noto K.A., et al. Extended survival by urgent liver retransplantation after using a first graft with metastasis from initially unrecognized donor sarcoma. Am J Transplant 2005, 5:1559-1561.
54. Kim J.K., Carmody I.C., Cohen A.J., et al. Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review. Clin Transplant 2009, 23:571-574.
55. Foltys D., Linkerman A., Heumann A., et al. Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case report. Transplant Proc 2009, 41:2639-2642.
56. Braun-Parvez L., Charlin E., Caillard S., et al. Gestational choriocarcinoma transmission following multiorgan donation. Am J Transplant 2010, 10:2541-2546.
57. Vernadakis S., Poetsch M., Weber F., et al. Donor origin de novo HCC in a noncirrhotic liver allograft 3 years after liver transplantation. Transpl Int 2010, 23:341-343.
58. Kauffman H.M., Cherikh W.S., McBride M.A., et al. Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update. Transplantation 2007, 84(2):272-274.
59. Buell J.F., Trofe J., Sethuraman G., et al. Donors with central nervous system malignancies: are they truly safe?. Transplantation 2003, 76(2):340-343.
60. Kashyap R., Ryan C., Sharma R., et al. Liver grafts from donors with central nervous system tumors: a single-center perspective. Liver Transpl 2009, 15:1204-1208.
61. Detry O. Liver graft procurement in donors with central nervous system cancers. Liver Transpl 2010, 16:914-915.
62. Penn I. Questions about the use of organ donors with tumors of the central nervous system. Transplantation 2000, 70(1):249-250.
63. Kaufman H.M., McBride M.A., Delmonico F.L. First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation 2000, 70(12):1747-1751.
64. Kauffman H.M., McBride M.A., Cheikh W.S., et al. Transplant tumor registry: donors with central nervous system tumors. Tranplantation 2002, 73(4):579-582.
65. Marroquin C.E., Marino G., Kuo P.C., et al. Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers. Liver Transpl 2001, 7(9):762-768.
66. Vargas H.E., Laskus T., Wang L.F., et al. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology 1999, 117:149-153.
67. Ahn J., Cohen S.M. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2008, 14:1603-1608.
68. Gruttadauria S., Pagano D., Petridis I., et al. Hepatitis C virus infection in a living-related liver donor. Am J Transplant 2010, 10:191.
69. Pereira B.J., Milford E.L., Kirkman R.L., et al. Transmission of hepatitis C virus by organ transplantation. N Engl J Med 1991, 325:454-460.
70. Northup P.G., Argo C.K., Nguyen D.T., et al. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis. Transpl Int 2010, 23:1038-1044.
71. Ghobrial R.M., Steadman R., Gornbein J., et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg 2001, 234(3):384-394.
72. Velidedeoglu E., Desai N.M., Campos L., et al. The outcome of liver grafts procured from hepatitis C-positive donors. Transplantation 2002, 73(4):582-587.
73. Saab S., Ghobrial R.M., Ibrahim A.B., et al. Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis. Am J Transplant 2003, 3:1167-1172.
74. Torres M., Weppler D., Reddy K.R., et al. Use of hepatitis C-infected donors for hepatitis C-positive OLT recipients. Gastroenterology 1999, 117:1253-1261.
75. Berenguer M. Risk of extended criteria donors in hepatitis C virus-positive recipients. Liver Transpl 2008, 14:S45-S50.
76. Martinez-Alarcon L., Rios A., Ramirez P., et al. Would patients with hepatitis C virus on the waiting list for a liver transplant accept a hepatitis C-positive organ?. Transpl Infect Dis 2009, 11:475-476.
77. Tector A.J., Mangus R.S., Chestovich P., et al. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg 2006, 244(3):439-450.
78. Alkofer B., Samstein B., Guarrera J.V., et al. Extended-donor criteria liver allografts. Semin Liver Dis 2006, 26:221-223.
79. Angelis M., Cooper J.T., Freeman R.B. Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transpl 2003, 9(5):451-462.
80. Marvin M.R., Brock G.N., Kwarteng K., et al. Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe?. Transplantation 2009, 87(8):1180-1190.
81. Zarranz J.J., Rouco I., Gomez-Esteban J.C. Human T lymphotropic virus type I (HTLV-I) associated myelopathy acquired through a liver transplant. J Neurol Neurosurg Psychiatry 2001, 71:817-824.
82. Zarranz-Imirizaldu J.J., Gomez-Esteban J.C., Rouco-Axpe I., et al. Post-transplantation HTLV-I myelopathy in three recipients from a single donor. J Neurol Neurosurg Psychiatry 2003, 74:1080-1084.
83. Toro C., Rodes B., Poveda E., et al. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation 2003, 75(1):102-104.
84. Gonzalez-Perez M.P., Munoz-Juarez L., Cardenas-Cardenas F., et al. Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor. Transplantation 2003, 75(7):1006-1011.
85. Kawano N., Shimoda K., Ishikawa F., et al. Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation. Transplantation 2006, 82(6):840-843.
86. Cuellar-Rodriguez J., Avery R.K., Lard M., et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009, 49:710-716.
87. Rodriguez-Hernandez M.J., Ruiz-Perez-Pipaon M., Canas E., et al. Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient. Am J Transplant 2009, 9:2637-2640.
88. Morelli M.C., Sambri V., Grazi G.L., et al. Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. Clin Infect Dis 2010, 51(4):e34-e37.
89. Mueller N.J., Weisser M., Fehr T., et al. Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor. Transpl Infect Dis 2010, 12:54-59.
90. Bennett W.M., Nespral J.F., Rosson M.W., et al. Use of organs for transplantation from a donor with primary meningoencephalitis due to Naegleria fowleri. Am J Transplant 2008, 8:1334-1335.
91. Iwamoto M., Jernigan D.B., Guasch A., et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003, 348:2196-2203.
92. West Nile Virus infections in organ transplant recipients-New York and Pennsylvania, August-September 2005. Centers for Disease Control and Prevention. MMWR Recomm Rep 2005, 54(40):1021-1023.
93. Srinivasan A., Burton E.C., Kuehnert M.J., et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005, 352:1103-1111.
94. Rabies in patients who received organ transplants in Germany. CDR Wkly (Online) 2005, 15. News.
95. Fischer S.A., Graham M.B., Kuehnert M.J., et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006, 354:2235-2249.
96. Palacios G., Druce J., Du L., et al. A new arenavirus in a cluster of fatal transplant-associated disease. N Engl J Med 2008, 358:991-998.
97. Baddley J.W., Schain D.C., Gupte A.A., et al. Transmission of Cryptococcus neoformans by organ transplantation. Clin Infect Dis 2011, 52(4):e94-e98.
98. Kusne S. Regarding unexpected severe and life-threatening donor-transmitted viral infections and use of high-risk behavior donors. Liver Transpl 2008, 14:1564-1568.
99. Wu T.J., Lee C.F., Chou H.S., et al. Suspect the donor with potential infection in the adult deceased donor liver transplantation. Transplant Proc 2008, 40:2486-2488.
100. Satoi S., Bramhall S.R., Solomon M., et al. The use of liver grafts from donors with bacterial meningitis. Transplantation 2001, 72(6):1108-1113.
101. Little D.M., Farrell J.G., Cunningham P.M., et al. Donor sepsis is not a contraindication to cadaveric organ donation. QJM 1997, 90:641-642.
102. Issa N.C., Patel R. Potential for expansion of the donor pool using liver allografts from donors with bacterial meningitis. Liver Transpl 2002, 8(10):977-979.
103. Simonds R.J., Holmberg S.D., Hurwitz R.L., et al. Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor. N Engl J Med 1992, 326(11):726-732.
104. Epidemiologic Notes and Reports Human Immunodeficiency Virus Infection Transmitted From on Organ Donor Screened for HIV Antibody - North Carolina. Centers for Disease Control and Prevention. MMWR Recomm Rep 1987, 36(20):306-308.
105. Ison M.G., Friedewald J.J. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation. Liver Transpl 2009, 15:561.
106. Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs. Centers for Disease Control and Prevention. MMWR Recomm Rep 1994, 43(RR-8):1-17.
107. Broering D.C., Topp S., Schaefer U., et al. Split liver transplantation and risk to the adult recipient: analysis using matched pairs. J Am Coll Surg 2002, 195:648-657.
108. Spada M., Cescon M., Aluffi A., et al. Use of extended right grafts from in situ split livers in adult liver transplantation: a comparison with whole-liver transplants. Transplant Proc 2005, 37:1164-1166.
109. Wilms C., Walter J., Kaptein M., et al. Long-term outcome of split liver transplantation using right extended grafts in adulthood: a matched pair analysis. Ann Surg 2006, 244(6):865-873.
110. Cescon M., Grazi G.L., Ravaioli M., et al. Conventional split liver transplantation for two adult recipients: a recent experience in a single European center. Transplantation 2009, 88:1117-1122.
111. Azoulay D., Castaing D., Adam R., et al. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg 2001, 233(4):565-574.
112. Decoster E.L., Troisi R., Sainz-Barriga M., et al. Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application?. Transplant Proc 2009, 41:3404-3406.
113. Humar A., Ramcharan T., Sielaff T.D., et al. Split liver transplantation for two adult recipients: an initial experience. Am J Transplant 2001, 1:366-372.
114. Baccarani U., Adani G.L., Risaliti A., et al. Long-term results of in situ split-liver transplantation. Transplant Proc 2005, 37:2592-2594.
115. Yersiz H., Renz J.F., Farmer D.G., et al. One hundred in situ split-liver transplantations: a single-center experience. Ann Surg 2003, 238(4):496-507.
116. Gundlach M., Broering D., Topp S., et al. Split-cava technique: liver splitting for two adult recipients. Liver Transpl 2000, 6(6):703-706.
117. Shiffman M.L., Brown R.S., Olthoff K.M., et al. Living donor liver transplantation: summary of a conference at The National Institutes of Health. Liver Transpl 2002, 8(2):174-188.
118. Olsen S.K., Brown R.S. Live donor liver transplantation: current status. Curr Gastroenterol Rep 2008, 10:36-42.
119. Olthoff K.M., Merion R.M., Ghobrial R.M., et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005, 242(3):314-325.
120. Olthoff K.M., Abecassis M.M., Emond J.C., et al. Outcomes for adult living donor transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl 2011, 17(7):789-797.
121. Hwang S., Lee S.G., Lee Y.J., et al. Lessons learned from 1,000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006, 12:920-927.
122. Shimazu M., Kitajima M. Living donor liver transplantation with special reference to ABO-incompatible grafts and small-for-size grafts. World J Surg 2004, 28:2-7.
123. Goldstein M.J., Salame E., Kapur S., et al. Analysis of failure in living donor liver transplantation: differential outcomes in children and adults. World J Surg 2003, 27:356-364.
124. Iida T., Ogura Y., Oike F., et al. Surgery-related morbidity in living donors for liver transplantation. Transplantation 2010, 89(10):1276-1282.
125. Ghobrial R.M., Freise C.E., Trotter J.F., et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008, 135:468-476.
126. Cotler S.J., Cotler S., Gambera M., et al. Adult living donor liver transplantation: perspectives from 100 liver transplant surgeons. Liver Transpl 2003, 9(6):637-644.